ARWR•benzinga•
Citigroup Maintains Neutral on Arrowhead Pharma, Lowers Price Target to $17
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 13, 2025 by benzinga